• Type:
  • Category:

Carl Zeiss Meditec AG Financial Results Q1 2021 / 22 | A Comprehensive Overview with CEO and CFO

Share

Excerpt

In this in-depth video presentation, Markus Weber, CEO, and Justus Felix Wehmer, CFO of Carl Zeiss Meditec AG, discuss the company’s financial performance during Q1-2021/22.

 

They provide an overview of the quarter’s results, including insights into the financials, new product releases, and the outlook for the future. As an MDAX- and TecDAX-listed company, Carl Zeiss Meditec AG is a leader in medical technology, specializing in ophthalmology and microsurgery solutions. With a global presence and a solid commitment to research and development, the company strives to continuously improve treatment results through innovative new products and increased efficiency.

 

Watch this comprehensive presentation to learn more about the company’s performance, products, and strategies.

Chapters

  • Introduction
  • Q1-2021/22: Overview
  • Q1-2021/22: Financials
  • New Products
  • Q1-2021/22: Outlook

Resources

Host

Dr. Markus Weber
CEO | Carl Zeiss Meditec AG

Justus Felix Wehmer
CFO | Carl Zeiss Meditec AG

Sebastian Frericks
Head IR | Carl Zeiss Meditec AG

Share

T&C:

This publication is for informational purposes only and should not be considered investment advice. By using this website, you agree to the terms and conditions outlined in the legal pages at www.seat11a.com/legal/

Discover Additional Elevator Pitches

Reviews for Carl Zeiss Meditec AG Financial Results Q1 2021 / 22 | A Comprehensive Overview with CEO and CFO

There are currently no reviews for Carl Zeiss Meditec AG Financial Results Q1 2021 / 22 | A Comprehensive Overview with CEO and CFO
Scroll to top